Dr Reddy’s Archives - Express Pharma

Express Pharma-Nutrify Today Boardroom series to be launched this February

Dr Reddy’s Lab Q3 results: Consolidated net profit up 77 per cent at Rs 1,247 crore

Dr Reddy’s completes clinical studies of rituximab biosimilar for filing in US and Europe

Dr Reddy’s reduces price of cardiovascular drug Cidmus

Dr Reddy’s launches in-house palbociclib to widen access to breast cancer drug

Dr Reddy’s completes phase-I study of proposed biosimilar of Tocilizumab

Dr Reddy’s and Sun Pharma recall products in US due to manufacturing issues

‘Science 2022 Top Employer List’ recognises two Indian pharma companies

Dr Reddy’s announces financial results for Q2 and H1 FY23

Glenmark, Sun Pharma and two others recall products in US